BCM
CO

Bayesian Capital Management’s Global Cord Blood Corporation CO Stock Holding History

Bayesian Capital Management’s Portfolio CO Stock Details CO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-16,460
Closed -$183K – 820
2017
Q3 		$183K Buy
+16,460
New +$193K 0.04% 434

Other funds holding CO

JCM
Jayhawk Capital Management Shawnee, Kansas $59.9M AUM 22.48% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
GP
GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
PG
PEAK6 Group Chicago, Illinois $23.4B AUM 17.65% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return

Bayesian Capital Management's CO Position: Q4 2017 in Review

Bayesian Capital Management sold out of Global Cord Blood Corporation (CO) in Q4 2017, closing a stake of 16,460 shares — an estimated $183K sold.

Bayesian Capital Management first reported a position in CO in Q3 2017 and held it in 1 quarter. The position peaked at $183K in Q3 2017. 50 funds tracked by Wall St. Rank hold CO as of Q4 2017.

  • Bayesian Capital Management reported no remaining Global Cord Blood Corporation position as of Q4 2017 after selling out during the quarter.
  • Bayesian Capital Management sold 16,460 Global Cord Blood Corporation shares in Q4 2017, an estimated $183K.
  • Bayesian Capital Management first reported a position in Global Cord Blood Corporation in Q3 2017 and held it in 1 quarter.
  • Bayesian Capital Management's Global Cord Blood Corporation position peaked at $183K in Q3 2017.
  • 50 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q4 2017.

Based on Bayesian Capital Management's 13F filing for Q4 2017, filed 12 Feb 2018.